Conformis, Inc.
CFMS · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $62 | $100 | $69 | $77 |
| % Growth | -37.9% | 45.2% | -11.2% | – |
| Cost of Goods Sold | $39 | $34 | $35 | $41 |
| Gross Profit | $23 | $66 | $34 | $37 |
| % Margin | 37.4% | 65.8% | 49% | 47.4% |
| R&D Expenses | $15 | $15 | $12 | $12 |
| G&A Expenses | $29 | $29 | $24 | $21 |
| SG&A Expenses | $54 | $54 | $47 | $49 |
| Sales & Mktg Exp. | $25 | $25 | $23 | $29 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $69 | $69 | $59 | $62 |
| Operating Income | -$46 | $0 | -$25 | -$25 |
| % Margin | -74.6% | 0.1% | -36.5% | -32.5% |
| Other Income/Exp. Net | -$4 | $1 | $1 | -$3 |
| Pre-Tax Income | -$50 | -$2 | -$24 | -$28 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$50 | -$2 | -$24 | -$28 |
| % Margin | -81.3% | -2.4% | -35.3% | -36.8% |
| EPS | -6.99 | -0.36 | -8.47 | -11.1 |
| % Growth | -1,841.7% | 95.7% | 23.7% | – |
| EPS Diluted | -6.99 | -0.36 | -8.47 | -11.1 |
| Weighted Avg Shares Out | 7 | 7 | 3 | 3 |
| Weighted Avg Shares Out Dil | 7 | 7 | 3 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $3 | $2 | $3 |
| Depreciation & Amortization | $0 | $4 | $0 | $0 |
| EBITDA | -$48 | $4 | -$22 | -$25 |
| % Margin | -78% | 4.3% | -31.7% | -32.5% |